Cellectis is a clinical-stage biopharmaceutical company that harnesses the immune system to target and eradicate cancer cells.
Cellectis is a clinical-stage biopharmaceutical company that harnesses the immune system to target and eradicate cancer cells.
Location:
8 Rue de la Croix Jarry, 75013 Paris, France
Categories:
The Synthetic Genome, Synthetic Cells Tissues and Beyond
Founded in:
1999
Employee number:
100+
Annual revenue:
$23M